article thumbnail

We need evidence-based digital health

World of DTC Marketing

A 2016 study reported that 259,000 digital health apps were available for consumers. A record number (296) of private digital health companies received venture funding in 2016, funding that totaled more than $4.2 Maybe, however, they should check with patients first. billion that year and approached $6 billion the following year.

Patients 244
article thumbnail

GAO Report on DTC/Medicare spending flawed

World of DTC Marketing

This report is going to lead to more calls to limit DTC advertising. 1ne: Medicare Parts B and D and beneficiaries spent $560 billion on drugs from 2016 through 2018, $324 billion spent on advertised drugs. Do DTC ads lead to increased patient knowledge of chronic health issues? So let’s look at the contents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Klick Health Acquires Peregrine Market Access, Further Cementing its Position as the Leading Go-To Commercialization Partner in Life Sciences

PM360

Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.

article thumbnail

The Top Sales Coaching Posts of 2016

The Brooks Group

Check out these popular sales coaching posts from 2016. Looking for the roadmap to building and leading an elite sales team? Implementing an effective coaching program optimized for coaching quality and quantity can help grow revenue up to 16.7% The Sales Coaching Best Practices Series: One-to-One Meetings. download.

Sales 49
article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

After aducanumab showed promise in 2016, Biogen launched two late-stage trials — then stopped them halfway through, in March 2019, when an analysis concluded the studies would not reach their goal of slowing cognitive and functional impairment in participants.

FDA 187
article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

According to JAMA , “in a cross-sectional study, between May 1, 2016, and May 31, 2021, there were 207 cancer drug approvals in oncology and malignant hematology. This leads to a question; “where does it end?” The biggest battle arena by far is oncology. ” The U.S.

Pharma 210